Gts Securities LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $6.28 Million - $7.92 Million	-50,500 Reduced 72.25%	19,400 $2.42 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $2.24 Million - $3.24 Million	19,800 Added 39.52%	69,900 $11 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $17.1 Million - $25.8 Million	-182,200 Reduced 78.43%	50,100 $6.49 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $6.56 Million - $12.2 Million	97,500 Added 72.33%	232,300 $22.4 Million
Q3 2023 Nov 15, 2023	BUY	$102.5 - $123.59 $13.8 Million - $16.7 Million	134,800 New	134,800 $16.3 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.